Publications
Selected publications
- Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus (Journal article - 2022)
- “It is good to have a target in mind”: Qualitative views of patients and parents informing a treat to target clinical trial in JSLE (Journal article - 2021)
- Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort Study (Journal article - 2021)
- Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK (Journal article - 2021)
- A Panel of Urinary Proteins Predicts Active Lupus Nephritis and Response to Rituximab Treatment (Journal article - 2020)
- Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts (Journal article - 2020)
- Establishing an international awareness day for paediatric rheumatic diseases: reflections from the inaugural World Young Rheumatic Diseases (WORD) Day 2019 (Journal article - 2020)
- Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis. (Journal article - 2019)
- A Markov Multi-State model of lupus nephritis urine biomarker panel dynamics in children: Predicting changes in disease activity (Journal article - 2019)
- International validation of a urinary biomarker panel for identification of active lupus nephritis in children. (Journal article - 2017)
2024
Contributors to Organ Damage in Childhood Lupus: Corticosteroid Use and Disease Activity.
Hanif, M., Sarker, C., Al-Abadi, E., Armon, K., Bailey, K., Bohm, M., . . . Smith, E. M. D. (2024). Contributors to Organ Damage in Childhood Lupus: Corticosteroid Use and Disease Activity.. Rheumatology (Oxford, England), keae592. doi:10.1093/rheumatology/keae592
Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research.
Sadun, R. E., Cooper, J. C., Belot, A., Avcin, T., Aggarwal, A., Ainsworth, J., . . . CARRA SLE Committee and PReS Lupus Working Party. (2024). Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research.. Annals of the rheumatic diseases, ard-2024-226528. doi:10.1136/ard-2024-226528
Childhood-Onset Systemic Lupus Erythematosus (cSLE): An International Perspective.
Aggarwal, A., Fernandes, T. A. P., Migowa, A., Smith, E. M. D., Hanif, M., Webb, K., & Lewandowski, L. B. (2024). Childhood-Onset Systemic Lupus Erythematosus (cSLE): An International Perspective.. Current allergy and asthma reports, 24(10), 559-569. doi:10.1007/s11882-024-01169-3
Cardiovascular risk in young people with childhood onset systemic lupus erythematosus.
Ciurtin, C., Robinson, G., Butt, M., Peng, J., Ardoin, S., Schanberg, L., . . . PReS Lupus Working Party and CARRA Lupus Group.. (2024). Cardiovascular risk in young people with childhood onset systemic lupus erythematosus.. The Lancet. Rheumatology, 6(5), e258-e263. doi:10.1016/s2665-9913(24)00085-7
P093 What’s in a name? Misnaming and renaming of Juvenile Idiopathic Arthritis has long-term impacts
Beesley, R. P., Beesley, R. M., Middleton, K., McBride, A., Smith, E. M. D., & Beresford, M. W. (2024). P093 What’s in a name? Misnaming and renaming of Juvenile Idiopathic Arthritis has long-term impacts. Rheumatology, 63(Supplement_1). doi:10.1093/rheumatology/keae163.134
Defining remission in childhood-onset lupus: PReS-endorsed consensus definitions by an international task force.
Smith, E. M. D., Aggarwal, A., Ainsworth, J., Al-Abadi, E., Avcin, T., Bortey, L., . . . Marks, S. D. (2024). Defining remission in childhood-onset lupus: PReS-endorsed consensus definitions by an international task force.. Clinical immunology (Orlando, Fla.), 110214. doi:10.1016/j.clim.2024.110214
Type I interferon associated epistasis may contribute to early disease-onset and high disease activity in juvenile-onset lupus.
Renaudineau, Y., Charras, A., Natoli, V., Fusaro, M., Smith, E. M. D., Beresford, M. W., . . . UK jSLE Cohort Study. (2024). Type I interferon associated epistasis may contribute to early disease-onset and high disease activity in juvenile-onset lupus.. Clinical immunology (Orlando, Fla.), 262, 110194. doi:10.1016/j.clim.2024.110194
2023
Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope.
Md Yusof, M. Y., Smith, E. M. D., Ainsworth, S., Armon, K., Beresford, M. W., Brown, M., . . . Vital, E. M. (2023). Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope.. Rheumatology advances in practice, 7(3), rkad093. doi:10.1093/rap/rkad093
Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforce.
Connelly, K., Eades, L. E., Koelmeyer, R., Ayton, D., Golder, V., Kandane-Rathnayake, R., . . . TRM-SLE Consortium. (2023). Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforce.. Nature reviews. Rheumatology, 19(9), 592-602. doi:10.1038/s41584-023-00993-7
Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force
Smith, E. M. D., Aggarwal, A., Ainsworth, J., Al-Abadi, E., Avcin, T., Bortey, L., . . . Beresford, M. W. (2023). Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force. ANNALS OF THE RHEUMATIC DISEASES, 82(6), 788-798. doi:10.1136/ard-2022-223328
OA39 Development of a Childhood Lupus Low Disease Activity State definition: recommendations from the International Childhood Lupus Treat-to-Target Task Force
Smith, E. M. D., Aggarwal, A., Ainsworth, J., Al-Abadi, E., Avcin, T., Bortey, L., . . . Beresford, M. W. (2023). OA39 Development of a Childhood Lupus Low Disease Activity State definition: recommendations from the International Childhood Lupus Treat-to-Target Task Force. Rheumatology, 62(Supplement_2). doi:10.1093/rheumatology/kead104.038
PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS)
Smith, E. M. D., Aggarwal, A., Ainsworth, J., Al-Abadi, E., Avcin, T., Bortey, L., . . . Beresford, M. W. (2023). PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS). CLINICAL IMMUNOLOGY, 250. doi:10.1016/j.clim.2023.109296
Current views on lupus in children
Smith, E. M. D., Lythgoe, H., & Hedrich, C. M. (2023). Current views on lupus in children. CURRENT OPINION IN RHEUMATOLOGY, 35(2), 68-81. doi:10.1097/BOR.0000000000000913
Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE
Charras, A., Haldenby, S., Smith, E. M. D., Egbivwie, N., Olohan, L., Kenny, J. G., . . . Hedrich, C. M. (2023). Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE. RHEUMATOLOGY, 62(SI2), SI210-SI225. doi:10.1093/rheumatology/keac275
2022
Improving communication of the concept of 'treat-to target' in childhood lupus: a public and patient (PPI) engagement project involving children and young people
Elliott, R. S., Taylor, E., Ainsworth, J., Preston, J., & Smith, E. M. D. S. (2022). Improving communication of the concept of 'treat-to target' in childhood lupus: a public and patient (PPI) engagement project involving children and young people. BMC RHEUMATOLOGY, 6(1). doi:10.1186/s41927-022-00300-z
The importance of children and young person involvement in scoping the need for a paediatric glucocorticoid-associated patient reported outcome measure
Singhal, S., Smith, E. M. D., Roper, L., & Pain, C. E. (2022). The importance of children and young person involvement in scoping the need for a paediatric glucocorticoid-associated patient reported outcome measure. BMC RHEUMATOLOGY, 6(1). doi:10.1186/s41927-022-00312-9
Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus
Smith, E. M. D., Tharmaratnam, K., Al-Abadi, E., Armon, K., Bailey, K., Brennan, M., . . . Beresford, M. W. (n.d.). Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus. Rheumatology. doi:10.1093/rheumatology/keab915
Research priority setting for paediatric rheumatology in the UK
Smith, E. M. D., Egbivwie, N., Cowan, K., Ramanan, A. V., & Pain, C. E. (2022). Research priority setting for paediatric rheumatology in the UK. LANCET RHEUMATOLOGY, 4(7), E517-E524. doi:10.1016/S2665-9913(22)00106-0
Real world treatment of juvenile-onset systemic lupus erythematosus: Data from the UK JSLE cohort study
Smith, E. M. D., Egbivwie, N., Jorgensen, A. L., Ciurtin, C., Al-Abadi, E., Armon, K., . . . Hedrich, C. M. (2022). Real world treatment of juvenile-onset systemic lupus erythematosus: Data from the UK JSLE cohort study. CLINICAL IMMUNOLOGY, 239. doi:10.1016/j.clim.2022.109028
OA32 UK Paediatric Rheumatology Clinical Studies Group research priorities - results of a multidisciplinary consultation and consensus exercise
Smith, E. M. D., Egbivwie, N., Cowan, K., Ramanan, A. V., & Pain, C. E. (2022). OA32 UK Paediatric Rheumatology Clinical Studies Group research priorities - results of a multidisciplinary consultation and consensus exercise. Rheumatology, 61(Supplement_1). doi:10.1093/rheumatology/keac132.032
What Have We Learnt About the Treatment of Juvenile-Onset Systemic Lupus Erythematous Since Development of the SHARE Recommendations 2012?
Gallagher, K. L., Patel, P., Beresford, M. W., & Smith, E. M. D. (2022). What Have We Learnt About the Treatment of Juvenile-Onset Systemic Lupus Erythematous Since Development of the SHARE Recommendations 2012?. FRONTIERS IN PEDIATRICS, 10. doi:10.3389/fped.2022.884634
Longitudinal analysis of urinary proteins in lupus nephritis – A pilot study
Carlsson, E., Quist, A., Davies, J. C., Midgley, A., Smith, E. M. D., Bruce, I. N., . . . Hedrich, C. M. (2022). Longitudinal analysis of urinary proteins in lupus nephritis – A pilot study. Clinical Immunology, 236, 108948. doi:10.1016/j.clim.2022.108948
Prospective epidemiological study of juvenile-onset systemic lupus erythematosus in the UK and Republic of Ireland
Lythgoe, H., Smith, E. M. D., Killeen, O. G., Murphy, R., Pilkington, C., Pain, C. E., & Beresford, M. W. (2022). Prospective epidemiological study of juvenile-onset systemic lupus erythematosus in the UK and Republic of Ireland. RHEUMATOLOGY. doi:10.1093/rheumatology/keac064
Development of Core and Expanded Datasets to Align Registries and Advance International Collaborative Research for Childhood-onset Systemic Lupus Erythematosus
Sadun, R., Lewandowski, L., Belot, A., Smith, E., & Cooper, J. (2022). Development of Core and Expanded Datasets to Align Registries and Advance International Collaborative Research for Childhood-onset Systemic Lupus Erythematosus. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 2713-2715). Retrieved from https://www.webofscience.com/
2021
Comment on: Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?: Reply
Smith, E. M. D., Beresford, M. W., McCann, L., & Hedrich, C. M. (2022). Comment on: Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?: Reply. RHEUMATOLOGY, 61(1), E27-E28. doi:10.1093/rheumatology/keab667
“It is good to have a target in mind”: Qualitative views of patients and parents informing a treat to target clinical trial in JSLE
Smith, E. M. D., Gorst, S. L., Al-Abadi, E., Hawley, D. P., Leone, V., Pilkington, C., . . . Young, B. (n.d.). “It is good to have a target in mind”: Qualitative views of patients and parents informing a treat to target clinical trial in JSLE. Rheumatology. doi:10.1093/rheumatology/keab173
1675 Real world treatment of juvenile systemic lupus erythematosus (JSLE): evidence from the UK JSLE cohort study
Egbivwie, N., Jorgensen, A. L., Beresford, M. W., Hedrich, C. M., & Smith, E. M. D. (2021). 1675 Real world treatment of juvenile systemic lupus erythematosus (JSLE): evidence from the UK JSLE cohort study. In Abstracts (pp. A454). BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health. doi:10.1136/archdischild-2021-rcpch.790
808 Prospective UK and Ireland population-based study of juvenile-onset systemic lupus erythematosus
Lythgoe, H., Smith, E. M. D., Killeen, O. G., Pilkington, C., Murphy, R., Pain, C. E., & Beresford, M. W. (2021). 808 Prospective UK and Ireland population-based study of juvenile-onset systemic lupus erythematosus. In Abstracts (pp. A121.2-A122). BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health. doi:10.1136/archdischild-2021-rcpch.211
Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study
Giani, T., Smith, E. M., Al-Abadi, E., Armon, K., Bailey, K., Ciurtin, C., . . . Hedrich, C. M. (2021). Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study. LUPUS, 30(12), 1955-1965. doi:10.1177/09612033211045050
Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK
Massias, J. S., Smith, E. M. D., Al-Abadi, E., Armon, K., Bailey, K., Ciurtin, C., . . . Hedrich, C. M. (2021). Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK. LUPUS, 30(4), 597-607. doi:10.1177/0961203320984251
Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort Study
Smith, E. M. D., Rasul, S., Ciurtin, C., Al-Abadi, E., Armon, K., Bailey, K., . . . Hedrich, C. M. (2021). Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort Study. RHEUMATOLOGY, 60(11), 5271-5281. doi:10.1093/rheumatology/keab210
Systemic Lupus Erythematosus in Children and Young People
Charras, A., Smith, E., & Hedrich, C. M. (2021). Systemic Lupus Erythematosus in Children and Young People. CURRENT RHEUMATOLOGY REPORTS, 23(3). doi:10.1007/s11926-021-00985-0
2020
A Panel of Urinary Proteins Predicts Active Lupus Nephritis and Response to Rituximab Treatment
Davies, J., Carlsson, E., Midgley, A., Smith, E., Bruce, I., Beresford, M., & Hedrich, C. (2020). A Panel of Urinary Proteins Predicts Active Lupus Nephritis and Response to Rituximab Treatment. ARTHRITIS & RHEUMATOLOGY, 72. Retrieved from http://gateway.webofknowledge.com/
Multidisciplinary collaboration among young specialists: results of an international survey by the emerging EULAR network and other young organisations
Najm, A., Kostine, M., Pauling, J. D., Ferreira, A. C., Stevens, K., Smith, E., . . . Sepriano, A. (2020). Multidisciplinary collaboration among young specialists: results of an international survey by the emerging EULAR network and other young organisations. RMD OPEN, 6(2). doi:10.1136/rmdopen-2020-001398
Establishing an international awareness day for paediatric rheumatic diseases: reflections from the inaugural World Young Rheumatic Diseases (WORD) Day 2019
Smith, E. M. D., Ainsworth, S., Beresford, M. W., Buys, V., Costello, W., Egert, Y., . . . Stones, S. R. (2020). Establishing an international awareness day for paediatric rheumatic diseases: reflections from the inaugural World Young Rheumatic Diseases (WORD) Day 2019. PEDIATRIC RHEUMATOLOGY, 18(1). doi:10.1186/s12969-020-00465-2
WORLD YOUNG RHEUMATIC DISEASES (WORD) DAY: THE FIRST INTERNATIONAL AWARENESS DAY FOR PAEDIATRIC RHEUMATIC DISEASES
Stones, S., Smith, E., Ainsworth, S., Buys, V., Costello, W., Egert, Y., . . . Scott, C. (2020). WORLD YOUNG RHEUMATIC DISEASES (WORD) DAY: THE FIRST INTERNATIONAL AWARENESS DAY FOR PAEDIATRIC RHEUMATIC DISEASES. In ANNALS OF THE RHEUMATIC DISEASES Vol. 79 (pp. 163). doi:10.1136/annrheumdis-2020-eular.1794
Clinical and Laboratory Characteristics in Juvenile-onset Systemic Lupus Erythematosus Across Age Groups
Massias, J., Smith, E., Beresford, M., & Hedrich, C. (2020). Clinical and Laboratory Characteristics in Juvenile-onset Systemic Lupus Erythematosus Across Age Groups. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 95-96). Retrieved from https://www.webofscience.com/
Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups
Massias, J. S., Smith, E. M. D., Al-Abadi, E., Armon, K., Bailey, K., Ciurtin, C., . . . Hedrich, C. M. (2020). Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups. LUPUS, 29(5), 474-481. doi:10.1177/0961203320909156
Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts
Belot, A., Rice, G. I., Omarjee, S. O., Rouchon, Q., Smith, E. M. D., Moreews, M., . . . Wood, F. (2020). Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts. The Lancet Rheumatology, 2(2), e99-e109. doi:10.1016/s2665-9913(19)30142-0
Neuropsychiatric Involvement in Juvenile-onset Systemic Lupus Erythematosus (JSLE): Data from the UK JSLE Cohort Study
Giani, T., Smith, E., Cimaz, R., Beresford, M., & Hedrich, C. (2020). Neuropsychiatric Involvement in Juvenile-onset Systemic Lupus Erythematosus (JSLE): Data from the UK JSLE Cohort Study. In ARTHRITIS & RHEUMATOLOGY Vol. 72. Retrieved from https://www.webofscience.com/
SJOGREN'S SYNDROME: A RETROSPECTIVE SERVICE EVALUATION OF DIAGNOSIS AND MANAGEMENT IN PAEDIATRIC PATIENTS
Close, R., Lant, A., Smith, E., Anderson, C. M., Deepak, S., Foster, R., . . . McErlane, F. (2020). SJOGREN'S SYNDROME: A RETROSPECTIVE SERVICE EVALUATION OF DIAGNOSIS AND MANAGEMENT IN PAEDIATRIC PATIENTS. In RHEUMATOLOGY Vol. 59. Retrieved from https://www.webofscience.com/
2019
Juvenile-onset systemic lupus erythematosus: Update on clinical presentation, pathophysiology and treatment options
Smith, E. M. D., Lythgoe, H., Midgley, A., Beresford, M. W., & Hedrich, C. M. (2019). Juvenile-onset systemic lupus erythematosus: Update on clinical presentation, pathophysiology and treatment options. CLINICAL IMMUNOLOGY, 209. doi:10.1016/j.clim.2019.108274
Diagnosis and treatment of childhood-onset systemic lupus erythematosus (European evidence-based recommendations from the SHARE initiative).
Smith, E. M. D., Sen, E. S., & Pain, C. E. (2019). Diagnosis and treatment of childhood-onset systemic lupus erythematosus (European evidence-based recommendations from the SHARE initiative).. Archives of disease in childhood. Education and practice edition, 104(5), 259-264. doi:10.1136/archdischild-2017-314049
DIAGNOSIS AND INITIAL MANAGEMENT OF JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS IN THE UK AND IRELAND
Lythgoe, H., Pain, C., Smith, E., & Beresford, M. (2019). DIAGNOSIS AND INITIAL MANAGEMENT OF JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS IN THE UK AND IRELAND. In ANNALS OF THE RHEUMATIC DISEASES Vol. 78 (pp. 1329). doi:10.1136/annrheumdis-2019-eular.1587
Vasculitis in juvenile-onset systemic lupus erythematosus
Smith, E. M., Lythgoe, H., & Hedrich, C. M. (2019). Vasculitis in juvenile-onset systemic lupus erythematosus. Frontiers in Pediatrics, 7(APR). doi:10.3389/fped.2019.00149
Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.
Smith, E., Al-Abadi, E., Armon, K., Bailey, K., Ciurtin, C., Davidson, J., . . . Hedrich, C. M. (2019). Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.. Lupus, 961203319836712. doi:10.1177/0961203319836712
A Markov Multi-State model of lupus nephritis urine biomarker panel dynamics in children: Predicting changes in disease activity
Smith, E. M. D., Eleuteri, A., Goilav, B., Lewandowski, L., Phuti, A., Rubinstein, T., . . . Beresford, M. W. (2019). A Markov Multi-State model of lupus nephritis urine biomarker panel dynamics in children: Predicting changes in disease activity. CLINICAL IMMUNOLOGY, 198, 71-78. doi:10.1016/j.clim.2018.10.021
Children and young people get rheumatic disease too.
Egert, Y., Egert, T., Costello, W., Prakken, B. J., Smith, E. M. D., & Wulffraat, N. M. (2019). Children and young people get rheumatic disease too.. The Lancet. Child & adolescent health, 3(1), 8-9. doi:10.1016/s2352-4642(18)30374-2
2018
Educational initiatives and training for paediatric rheumatology in Europe
Foster, H. E., Vojinovic, J., Constantin, T., Martini, A., Dolezalova, P., Uziel, Y., . . . Wulffraat, N. (2018). Educational initiatives and training for paediatric rheumatology in Europe. PEDIATRIC RHEUMATOLOGY, 16. doi:10.1186/s12969-018-0289-y
Growing international evidence for urinary biomarker panels identifying lupus nephritis in children - verification within the South African Paediatric Lupus Cohort
Smith, E. M. D., Lewandowski, L. B., Jorgensen, A. L., Phuti, A., Nourse, P., Scott, C., & Beresford, M. W. (2018). Growing international evidence for urinary biomarker panels identifying lupus nephritis in children - verification within the South African Paediatric Lupus Cohort. LUPUS, 27(14), 2190-2199. doi:10.1177/0961203318808376
Clinical predictors of active LN development in children - evidence from the UK JSLE Cohort Study
Smith, E. M. D., Yin, P., Jorgensen, A. L., & Beresford, M. W. (2018). Clinical predictors of active LN development in children - evidence from the UK JSLE Cohort Study. LUPUS, 27(13), 2020-2028. doi:10.1177/0961203318801526
MULTIDISCIPLINARY COLLABORATION AMONG YOUNG SPECIALISTS: RESULTS OF AN ONGOING INTERNATIONAL SURVEY BY YOUNG ORGANISATIONS
Kostine, M., Najm, A., Pauling, J., Ferreira, A. C., Stevens, K., Smith, E., . . . Richez, C. (2018). MULTIDISCIPLINARY COLLABORATION AMONG YOUNG SPECIALISTS: RESULTS OF AN ONGOING INTERNATIONAL SURVEY BY YOUNG ORGANISATIONS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 77 (pp. 198-199). doi:10.1136/annrheumdis-2018-eular.7004
Juvenile-onset systemic lupus erythematosus (jSLE) - Pathophysiological concepts and treatment options
Hedrich, C. M., Smith, E. M. D., & Beresford, M. W. (2018). Juvenile-onset systemic lupus erythematosus (jSLE) - Pathophysiological concepts and treatment options. Best Practice and Research: Clinical Rheumatology. doi:10.1016/j.berh.2018.02.001
Clinical predictors of proteinuric remission following an LN flare - evidence from the UK JSLE cohort study
Smith, E. M. D., Yin, P., Jorgensen, A., & Beresford, M. (2018). Clinical predictors of proteinuric remission following an LN flare - evidence from the UK JSLE cohort study. Pediatric Rheumatology Online Journal, 16(1). doi:10.1186/s12969-018-0230-4
2017
29. Lupus and You: Developing a workshop for young people with lupus and their families
Wilson, E., Lythgoe, H., Smith, E., Preston, J., & Beresford, M. W. (2017). 29. Lupus and You: Developing a workshop for young people with lupus and their families. Rheumatology, 56(suppl_7). doi:10.1093/rheumatology/kex390.029
30. Using a pre-clinic screening tool to support young people with lupus in prioritising issues for discussion in clinic appointments
Wilson, E., Etheridge, J., Smith, E., & Beresford, M. W. (2017). 30. Using a pre-clinic screening tool to support young people with lupus in prioritising issues for discussion in clinic appointments. Rheumatology, 56(suppl_7). doi:10.1093/rheumatology/kex390.030
6. Developing a UK/ROI study of the incidence of JSLE in children and young people and their access to care: a collaborative approach
Lythgoe, H., Smith, E., Pain, C., Murphy, R., Killeen, O., Pilkington, C., & Beresford, M. W. (2017). 6. Developing a UK/ROI study of the incidence of JSLE in children and young people and their access to care: a collaborative approach. Rheumatology, 56(suppl_7). doi:10.1093/rheumatology/kex390.006
USING A PRE-CLINIC SCREENING TOOL TO SUPPORT YOUNG PEOPLE WITH LUPUS IN PRIORITISING ISSUES FOR DISCUSSION IN CLINIC APPOINTMENTS
Wilson, E., Etheridge, J., Smith, E., & Beresford, M. W. (2017). USING A PRE-CLINIC SCREENING TOOL TO SUPPORT YOUNG PEOPLE WITH LUPUS IN PRIORITISING ISSUES FOR DISCUSSION IN CLINIC APPOINTMENTS. In RHEUMATOLOGY Vol. 56 (pp. 19-20). Retrieved from https://www.webofscience.com/
Urinary biomarkers in childhood lupus nephritis
Smith, E. M. D., & Beresford, M. W. (2017). Urinary biomarkers in childhood lupus nephritis. CLINICAL IMMUNOLOGY, 185, 21-31. doi:10.1016/j.clim.2016.06.010
Developing an Education Resource for the paediatric BILAG index
Richards, E., Poutney, M., Holt, A., Prescott, D., Smith, E., Roberts, C., & Beresford, M. (2017). Developing an Education Resource for the paediatric BILAG index. In RHEUMATOLOGY Vol. 56. doi:10.1093/rheumatology/kex356.019
Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study.
Smith, E. M. D., Jorgensen, A. L., & Beresford, M. W. (2017). Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study.. Lupus, 26(11), 1212-1217. doi:10.1177/0961203317702253
G433(P) Lupus and you: developing a workshop for young people with lupus and their families
Wilson, E. R. H., Lythgoe, H., Smith, E., Preston, J., & Beresford, M. W. (2017). G433(P) Lupus and you: developing a workshop for young people with lupus and their families. In British Society for Paediatric and Adolescent Rheumatology and British Paediatric Respiratory Society (pp. A170.2-A171). BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health. doi:10.1136/archdischild-2017-313087.426
G434(P) Using a pre-clinic screening tool to support young people with lupus in prioritising issues for discussion in clinic appointments
Wilson, E., Etheridge, J., Smith, E., & Beresford, M. (2017). G434(P) Using a pre-clinic screening tool to support young people with lupus in prioritising issues for discussion in clinic appointments. In British Society for Paediatric and Adolescent Rheumatology and British Paediatric Respiratory Society (pp. A171.1-A171). BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health. doi:10.1136/archdischild-2017-313087.427
Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part one
De Benedetti, F., Anton, J., Gattorno, M., Lachmann, H., Kone-Paut, I., Ozen, S., . . . Pruunsild, C. (2017). Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part one. Pediatric Rheumatology, 15(S1). doi:10.1186/s12969-017-0141-9
Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part three
Papa, R., Consolaro, A., Minoia, F., Caorsi, R., Magnano, G., Gattorno, M., . . . La Manna, A. (2017). Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part three. Pediatric Rheumatology, 15(S1). doi:10.1186/s12969-017-0143-7
Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two
Lomakina, O., Alekseeva, E., Valieva, S., Bzarova, T., Nikishina, I., Zholobova, E., . . . Rose, C. (2017). Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two. Pediatric Rheumatology, 15(S1). doi:10.1186/s12969-017-0142-8
International validation of a urinary biomarker panel for identification of active lupus nephritis in children.
Smith, E. M. D., Jorgensen, A. L., Midgley, A., Oni, L., Goilav, B., Putterman, C., . . . Beresford, M. W. (2017). International validation of a urinary biomarker panel for identification of active lupus nephritis in children.. Pediatric Nephrology, 32(2), 283-295. doi:10.1007/s00467-016-3485-3
DEVELOPING A UK/ROI STUDY OF THE INCIDENCE OF JSLE IN CHILDREN AND YOUNG PEOPLE AND THEIR ACCESS TO CARE: A COLLABORATIVE APPROACH
Lythgoe, H., Smith, E., Pain, C., Murphy, R., Killeen, O., Pilkington, C., & Beresford, M. W. (2017). DEVELOPING A UK/ROI STUDY OF THE INCIDENCE OF JSLE IN CHILDREN AND YOUNG PEOPLE AND THEIR ACCESS TO CARE: A COLLABORATIVE APPROACH. In RHEUMATOLOGY Vol. 56 (pp. 3-+). Retrieved from https://www.webofscience.com/
LUPUS AND YOU: DEVELOPING A WORKSHOP FOR YOUNG PEOPLE WITH LUPUS AND THEIR FAMILIES
Wilson, E., Lythgoe, H., Smith, E., Preston, J., & Beresford, M. W. (2017). LUPUS AND YOU: DEVELOPING A WORKSHOP FOR YOUNG PEOPLE WITH LUPUS AND THEIR FAMILIES. In RHEUMATOLOGY Vol. 56. Retrieved from https://www.webofscience.com/
2016
Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis.
Campanilho-Marques, R., Almeida, B., Deakin, C., Arnold, K., Gallot, N., de Iorio, M., . . . Juvenile Dermatomyositis Research Group. (2016). Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis.. Arthritis care & research, 68(10), 1514-1521. doi:10.1002/acr.22867
Developing a Lupus Nephritis urinary biomarker panel in children for use in a clinical trial
Smith, E. M. D. (2016, August 15). Developing a Lupus Nephritis urinary biomarker panel in children for use in a clinical trial.
Developing a Lupus Nephritis urinary biomarker panel in children for use in a clinical trial (ABRIDGED VERSION)
Smith, E. M. (2016, August 15). Developing a Lupus Nephritis urinary biomarker panel in children for use in a clinical trial (ABRIDGED VERSION).
Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis
Patel, M., Oni, L., Midgley, A., Smith, E., Tullus, K., Marks, S. D., . . . Beresford, M. W. (2016). Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis. LUPUS, 25(9), 1040-1044. doi:10.1177/0961203316631634
EXPERIENCES FROM YOUNG REPRESENTATIVE OF PAEDIATRIC RHEUMATOLOGY EUROPEAN SOCIETY
Smith, E. (2016). EXPERIENCES FROM YOUNG REPRESENTATIVE OF PAEDIATRIC RHEUMATOLOGY EUROPEAN SOCIETY. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 15). doi:10.1136/annrheumdis-2016-eular.6424
Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus
Thorbinson, C., Oni, L., Smith, E., Midgley, A., & Beresford, M. W. (2016). Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus. PEDIATRIC DRUGS, 18(3), 181-195. doi:10.1007/s40272-016-0170-8
2015
THU0522 Plasma TNFR1 and TNFR2 in Active Paediatric Lupus Nephritis
Patel, M., Oni, L., Jeffers, G., Smith, E., Midgley, A., Tullus, K., . . . Beresford, M. (2015). THU0522 Plasma TNFR1 and TNFR2 in Active Paediatric Lupus Nephritis. Annals of the Rheumatic Diseases, 74(Suppl 2), 389.2-389. doi:10.1136/annrheumdis-2015-eular.4921
DEVELOPING A URINARY BIOMARKER PANEL FOR MONITORING LUPUS NEPHRITIS DISEASE ACTIVITY
Smith, E. M. D., Corkhill, R., Midgley, A., Watson, L., Jones, C., Marks, S. D., . . . Beresford, M. W. (2015). DEVELOPING A URINARY BIOMARKER PANEL FOR MONITORING LUPUS NEPHRITIS DISEASE ACTIVITY. In RHEUMATOLOGY Vol. 54 (pp. 3). doi:10.1093/rheumatology/keu492
SP864THE RENAL STATUS OF THE UK JUVENILE-SLE COHORT
Oni, L., Richards, E., Smith, E., & Beresford, M. W. (2015). SP864THE RENAL STATUS OF THE UK JUVENILE-SLE COHORT. Nephrology Dialysis Transplantation, 30(suppl_3), iii662. doi:10.1093/ndt/gfv203.02
SaO042AN EXCELLENT BIOMARKER PANEL FOR IDENTIFICATION OF ACTIVE LUPUS NEPHRITIS IN CHILDREN
Smith, E. M. D. D., Oni, L., Midgley, A., Tullus, K., Pilkington, C., Marks, S., . . . Beresford, M. W. (2015). SaO042AN EXCELLENT BIOMARKER PANEL FOR IDENTIFICATION OF ACTIVE LUPUS NEPHRITIS IN CHILDREN. Nephrology Dialysis Transplantation, 30(suppl_3), iii41. doi:10.1093/ndt/gfv153.05
G471 The renal status of the uk juvenile – sle cohort
Oni, L., Richards, E., Smith, E., & Beresford, M. W. (2015). G471 The renal status of the uk juvenile – sle cohort. Archives of Disease in Childhood, 100(Suppl 3), A198.2-A198. doi:10.1136/archdischild-2015-308599.425
The development and assessment of biological treatments for children
Smith, E. M. D., Foster, H. E., & Beresford, M. W. (2015). The development and assessment of biological treatments for children. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 79(3), 379-394. doi:10.1111/bcp.12406
AN EXCELLENT BIOMARKER PANEL FOR IDENTIFICATION OF ACTIVE LUPUS NEPHRITIS IN CHILDREN
Smith, E. M. D. D., Oni, L., Midgley, A., Tullus, K., Pilkington, C., Marks, S., . . . Beresford, M. W. (2015). AN EXCELLENT BIOMARKER PANEL FOR IDENTIFICATION OF ACTIVE LUPUS NEPHRITIS IN CHILDREN. In NEPHROLOGY DIALYSIS TRANSPLANTATION Vol. 30. doi:10.1093/ndt/gfv153.5
2014
INVESTIGATING BIOMARKERS OF DISEASE ACTIVITY IN JUVENILE-ONSET LUPUS NEPHRITIS
Smith, E. M. D., Watson, L., Jones, C., Pilkington, C. A., Marks, S. D., Tullus, K., & Beresford, M. W. (2014). INVESTIGATING BIOMARKERS OF DISEASE ACTIVITY IN JUVENILE-ONSET LUPUS NEPHRITIS. In RHEUMATOLOGY Vol. 53 (pp. 21). Retrieved from https://www.webofscience.com/
Urinary VCAM-1 as a biomarker of lupus nephritis disease activity
Smith, E., Corkhill, R., Midgley, A., Watson, L., Jones, C., Marks, S., . . . Beresford, M. W. (2014). Urinary VCAM-1 as a biomarker of lupus nephritis disease activity. Pediatric Rheumatology, 12(S1). doi:10.1186/1546-0096-12-s1-p108
331. Relative Expression of Kidney-Associated Proteins in Lupus Nephritis: Identifying Future Urinary Biomarker Targets for Disease Monitoring
Smith, E. M. D., Midgley, A., Watson, L., Jones, C., Pilkington, C., Marks, S. D., . . . Beresford, M. W. (2014). 331. Relative Expression of Kidney-Associated Proteins in Lupus Nephritis: Identifying Future Urinary Biomarker Targets for Disease Monitoring. Rheumatology, 53(suppl_1), i183-i184. doi:10.1093/rheumatology/keu128.011
Predictors of access to care in juvenile systemic lupus erythematosus: evidence from the UK JSLE Cohort Study
Smith, E. M. D., Foster, H. E., Gray, W. K., Taylor-Robinson, D., & Beresford, M. W. (2014). Predictors of access to care in juvenile systemic lupus erythematosus: evidence from the UK JSLE Cohort Study. RHEUMATOLOGY, 53(3), 557-561. doi:10.1093/rheumatology/ket402
2013
Fifteen-minute consultation: A structured approach to the management of hypermobility in a child.
Smith, E. M. D., & Ramanan, A. V. (2013). Fifteen-minute consultation: A structured approach to the management of hypermobility in a child.. Archives of disease in childhood. Education and practice edition, 98(6), 212-216. doi:10.1136/archdischild-2013-303882
AB0658 Predictors of access to care in JSLE - evidence from the UK JSLE cohort study
Smith, E., Taylor-Robinson, D., Gray, W., Foster, H. E., & Beresford, M. W. (2013). AB0658 Predictors of access to care in JSLE - evidence from the UK JSLE cohort study. Annals of the Rheumatic Diseases, 71(Suppl 3), 676.8-676. doi:10.1136/annrheumdis-2012-eular.658
Adding to complexity: comorbidity in paediatric rheumatic disease
Smith, E. M. D., Foster, H. E., & Beresford, M. W. (2013). Adding to complexity: comorbidity in paediatric rheumatic disease. RHEUMATOLOGY, 52(1), 22-33. doi:10.1093/rheumatology/kes256
2012
Acceptability and practicality of pGALS in screening for rheumatic disease in Malawian children.
Smith, E., Molyneux, E., Heikens, G. T., & Foster, H. (2012). Acceptability and practicality of pGALS in screening for rheumatic disease in Malawian children.. Clinical rheumatology, 31(4), 647-653. doi:10.1007/s10067-011-1901-4
PREDICTORS OF ACCESS TO CARE IN JSLE: EVIDENCE FROM THE UK JSLE COHORT STUDY
Smith, E., Gray, W., Taylor-Robinson, D., Foster, H. E., & Beresford, M. W. (2012). PREDICTORS OF ACCESS TO CARE IN JSLE: EVIDENCE FROM THE UK JSLE COHORT STUDY. In RHEUMATOLOGY Vol. 51 (pp. 8-9). Retrieved from https://www.webofscience.com/
PREDICTORS OF ACCESS TO CARE IN JSLE: EVIDENCE FROM THE UK JSLE COHORT STUDY
Smith, E., Gray, W., Taylor-Robinson, D., Foster, H. E., & Beresford, M. W. (2012). PREDICTORS OF ACCESS TO CARE IN JSLE: EVIDENCE FROM THE UK JSLE COHORT STUDY. In RHEUMATOLOGY Vol. 51 (pp. 8-9). Retrieved from https://www.webofscience.com/
The child with a limp: a symptom and not a diagnosis.
Smith, E., Anderson, M., & Foster, H. (2012). The child with a limp: a symptom and not a diagnosis.. Archives of disease in childhood. Education and practice edition, 97(5), 185-193. doi:10.1136/archdischild-2011-301245
2010
An unusual cause of neonatal respiratory distress.
Smith, E., Kumar, R., Barron, R., & Bosman, D. (2010). An unusual cause of neonatal respiratory distress.. BMJ case reports, 2010, bcr0520103022. doi:10.1136/bcr.05.2010.3022
2006
Endothelial nitric oxide synthase polymorphisms do not influence pulmonary artery systolic pressure at altitude.
Smith, E. M. D., Baillie, J. K., Thompson, A. A. R., Irving, J. B., Porteous, D., & Webb, D. J. (2006). Endothelial nitric oxide synthase polymorphisms do not influence pulmonary artery systolic pressure at altitude.. High altitude medicine & biology, 7(3), 221-227. doi:10.1089/ham.2006.7.221